S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
MarketBeat Week in Review – 9/25 - 9/29
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
MarketBeat Week in Review – 9/25 - 9/29
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
MarketBeat Week in Review – 9/25 - 9/29
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
MarketBeat Week in Review – 9/25 - 9/29
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
OTCMKTS:RNUGF

ReNeuron Group (RNUGF) Stock Forecast, Price & News

$0.09
0.00 (0.00%)
(As of 09/29/2023 ET)
Compare
Today's Range
$0.09
$0.09
50-Day Range
$0.07
$0.09
52-Week Range
$0.07
$0.34
Volume
N/A
Average Volume
N/A
Market Capitalization
$5.26 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

RNUGF stock logo

About ReNeuron Group (OTCMKTS:RNUGF) Stock

ReNeuron Group plc researches, develops, and commercializes cell-based therapies in the United Kingdom. The company engages in the development of CTX stem cell therapy candidate for treating stroke disability; and human retinal progenitor cell therapy that is in Phase 2 clinical trial for treating retinitis pigmentosa, a blindness-causing disease. It also develops CTX-derived exosomes that are in the pre-clinical stage, which are Nano-sized vesicles secreted by stem cells. In addition, the company licenses ReNcell products. It has a collaboration agreement with University College London to conduct research into the generation of immune cells from induced pluripotent stem cells for anti-cancer cell therapies. The company was founded in 1997 and is headquartered in Pencoed, the United Kingdom.

RNUGF Price History

RNUGF Stock News Headlines

ReNeuron appoints new scientific advisory board
Are "The Magnificent Seven" the Next Sears?
The former retail giant’s sales once accounted for 1% of the U.S. economy. Now it’s nearly extinct. Will the same happen to big tech? Learn more here.
ReNeuron says positive iPSC data presented at conference
ReNeuron Group says positive iPSC data presented at conference
ReNeuron Group Names John Hawkins CFO - Quick Facts
Are "The Magnificent Seven" the Next Sears?
The former retail giant’s sales once accounted for 1% of the U.S. economy. Now it’s nearly extinct. Will the same happen to big tech? Learn more here.
ReNeuron Update Regarding COVID-19
See More Headlines
Receive RNUGF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ReNeuron Group and its competitors with MarketBeat's FREE daily newsletter.

RNUGF Company Calendar

Today
10/01/2023
Fiscal Year End
3/31/2024

Industry, Sector and Symbol

Industry
Private households
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:RNUGF
Previous Symbol
NASDAQ:RNUGF
CIK
N/A
Fax
N/A
Employees
26
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$540,000.00

Miscellaneous

Free Float
N/A
Market Cap
$5.26 million
Optionable
Not Optionable
Beta
0.99
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Mr. Iain Gladstone Ross B.Sc. (Age 69)
    BSc (Hons), C.DIR, CH.D, Exec. Chairman
    Comp: $532.55k
  • Mr. John Michael Hawkins A.C.A. (Age 56)
    Company Sec., CFO & Director
    Comp: $238.92k
  • Dr. John David Sinden B.A. (Age 72)
    BA, M.A., MA, Ph.D., Co-Founder
  • Ms. Suzanne Hancock
    Chief Operations Officer
  • Dr. Randolph Corteling Ph.D.
    Chief Scientific Officer
  • Mr. Simon Dew
    Chief Bus. Officer













RNUGF Stock - Frequently Asked Questions

How have RNUGF shares performed in 2023?

ReNeuron Group's stock was trading at $0.10 at the start of the year. Since then, RNUGF shares have decreased by 8.0% and is now trading at $0.0920.
View the best growth stocks for 2023 here
.

What is ReNeuron Group's stock symbol?

ReNeuron Group trades on the OTCMKTS under the ticker symbol "RNUGF."

How do I buy shares of ReNeuron Group?

Shares of RNUGF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ReNeuron Group's stock price today?

One share of RNUGF stock can currently be purchased for approximately $0.09.

How much money does ReNeuron Group make?

ReNeuron Group (OTCMKTS:RNUGF) has a market capitalization of $5.26 million and generates $540,000.00 in revenue each year.

How can I contact ReNeuron Group?

ReNeuron Group's mailing address is Pencoed Business Park Bridgend, Pencoed X0, CF35 5HY. The official website for the company is www.reneuron.com. The company can be reached via phone at 44-20-3819-8400 or via email at reneuron@walbrookpr.com.

This page (OTCMKTS:RNUGF) was last updated on 10/1/2023 by MarketBeat.com Staff

My Account -